Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith

Details for Australian Patent Application No. 2006265784 (hide)

Owner Bristol-Myers Squibb Company

Inventors Mastalerz, Harold; Trainor, George L.; Vyas, Dolatrai M.; Gavai, Ashvinikumar V.

Agent A J Park

Pub. Number AU-B-2006265784

PCT Pub. Number WO2007/005708

Priority 60/696,215 01.07.05 US

Filing date 29 June 2006

Wipo publication date 11 January 2007

Acceptance publication date 1 March 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

24 January 2008 PCT application entered the National Phase

  PCT publication WO2007/005708 Priority application(s): WO2007/005708

1 March 2012 Application Accepted

  Published as AU-B-2006265784

28 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006265787-Polymer interlayers comprising poly(cyclohexanedimethylene terephthalate-co-ethylene terephthalate) copolyester

2006265783-Composite component production using fluid density and pressure